INS and diabetes mellitus: Patients with diabetes exhibit an impaired counterregulatory response to hypoglycemic events, such as a suboptimal release of glucagon, cortisol, and epinephrine, which stimulate glycogenolysis and gluconeogenesis and inhibit insulin secretion [27].